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Purpose: To provide a comprehensive summary of all clini-
cal evidence on Chinese herbal medicine (CHM) for idiopathic
sudden sensorineural hearing loss (ISSHL) published in Chi-
nese literature.
Methods: We systematically searched randomized clini-
cal trials (RCTs), clinical controlled trials (CCTs), case series
(CSs) and case reports (CRs) which reported CHM for ISSHL
through four main Chinese electronic databases from their
inception to March 2014. We bibliometrically analyzed the
studies and assessed themethodological quality of RCTsusing
the Cochrane risk of bias tool.
Results: A total of 299 clinical studies with involving 22,237
participants were identiﬁed including 150 RCTs, 42 CCTs,
80 CSs and 27 CRs. The number of publications increased
obviously per year from 1995, with the peak in 2011. Among
145 different herbal formulae tested, the most popular pre-
scribed herbal formulae were Longdan Xiegan decoction and
TongqiaoHuoxue decoction, and the top three frequently used
Chinese herbs were Rhizoma Chuanxiong, Radix Bupleuri and
Radix Puerariae Lobatae. The most frequently reported out-
come was improvement of hearing in 286 (95.7%), followed by
improvement of tinnitus (139, 46.5%), improvement of dizzi-
ness (99, 33.1%). Among the 150 RCTs, randomizationmethods
were described in only 12 trials (8.0%). No trial reported alloca-
tion concealment and only four mentioned blinding. Among
146 RCTs (97.3%) and 37 CCTs (88.1%) reporting improvement
of hearing as the outcome measurement, all showed signif-
icant difference favoring CHM. Of 16 trials reporting adverse
events, only ﬁve trials reported mild adverse events related to
CHM and the remaining stated that none had occurred.
Conclusion: The quantity of clinical research on CHM for
ISSHL is substantial, but methodological quality of RCTs is
generally suboptimal. Future clinical studies would need to
report structurally and based on the CONSORT and TREND
Statements. Quality of life, adverse events, depression and
anxiety should be addressed as outcome measures.
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Empirical evidence for outcome reporting
bias in randomized clinical trials of
acupuncture: comparison of registered
records and subsequent publications
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Purpose: To evaluate the consistency between the reg-
istered records and subsequent publications regarding
outcomes and other data, and to determine whether
outcome reporting bias favored signiﬁcant primary
outcomes.
Methods: We systematically searched 15 registries from
their inception to January 2014 to identify randomized
clinical trials (RCTs) on acupuncture that the status was
listed as ‘completed’. The subsequent publications were
retrieved by searching PubMed and three Chinese databases.
Basic characteristics and the registration information were
extracted from registered records and publications. We
performed comparisons regarding primary outcomes and
other data between the registered records and publica-
tions to assess the consistency and selective outcome
reporting.
Results: Eighty-eight trials on acupuncture with 96 pub-
lications were identiﬁed. Only 19.3% (17/88) were registered
before the start of the trial. The trial registered number was
not reported in 36 publications (25.9%). A comparison of
registered and published primary outcomes could be con-
ducted in 71 publications (74.0%), and the inconsistency of
the primary outcomes was identiﬁed in 44.4% (32 of 71),
mainly involving in registered primary outcomeomitted in the
publications (22/32, 68.75%), followed by registered primary
outcome reported as secondary outcome in the publications
(15/32, 46.9%). 71.4% (15 of 21) had a discrepancy that favored
statistically signiﬁcant primary outcomeswhile 28.6% (6 of 21)
favored nonsigniﬁcant primary outcomes. Furthermore, the
other inconsistencies between the registry records and publi-
cations involved in inclusion criteria (54.7%), exclusion criteria
(47.9%), and control (22.9%).
Conclusion: We ﬁnd that the proportion of retrospec-
tive registration for RCTs on acupuncture is high, selective
outcome reporting is prevalent, and the change of primary
outcomes intends to favor results with statistical signiﬁ-
cance. These discrepancies in outcome reporting may lead
to biased and misleading results of RCTs on acupuncture.
To ensure publication of reliable and unbiased results, fur-
ther promotion and implementation of trial registration is still
needed.
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